DK0467331T3 - O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler - Google Patents

O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler

Info

Publication number
DK0467331T3
DK0467331T3 DK91111948.5T DK91111948T DK0467331T3 DK 0467331 T3 DK0467331 T3 DK 0467331T3 DK 91111948 T DK91111948 T DK 91111948T DK 0467331 T3 DK0467331 T3 DK 0467331T3
Authority
DK
Denmark
Prior art keywords
azithromycin
methyl derivatives
co2ch2c6h5
derivatives
methyl
Prior art date
Application number
DK91111948.5T
Other languages
English (en)
Inventor
Gabrijela Kobrehel
Slobodan Djokic
Gorjana Lazarevski
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Application granted granted Critical
Publication of DK0467331T3 publication Critical patent/DK0467331T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91111948.5T 1990-07-18 1991-07-17 O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler DK0467331T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU140990 1990-07-18

Publications (1)

Publication Number Publication Date
DK0467331T3 true DK0467331T3 (da) 1996-02-05

Family

ID=25554060

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91111948.5T DK0467331T3 (da) 1990-07-18 1991-07-17 O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler

Country Status (20)

Country Link
US (1) US5250518A (da)
EP (1) EP0467331B1 (da)
JP (1) JP2657132B2 (da)
CN (1) CN1029738C (da)
AT (1) ATE129715T1 (da)
BG (1) BG60593B1 (da)
CA (1) CA2046956C (da)
CZ (1) CZ280640B6 (da)
DE (1) DE69114198T2 (da)
DK (1) DK0467331T3 (da)
ES (1) ES2081397T3 (da)
GR (1) GR3018330T3 (da)
HR (1) HRP920491B1 (da)
HU (4) HU221803B1 (da)
PL (1) PL166379B1 (da)
RO (1) RO109338B1 (da)
RU (1) RU2045533C1 (da)
SI (1) SI9011409A (da)
SK (1) SK279075B6 (da)
UA (1) UA27105A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
DK1036083T5 (da) * 1997-10-16 2005-04-04 Pliva Istrazivacki Inst D O O Nye 9A-azalider
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
RU2122549C1 (ru) * 1997-12-29 1998-11-27 Закрытое акционерное общество "Фосфосорб" Способ хроматографического выделения и очистки белков, пептидов и их комплексов
HRP970714B1 (en) * 1997-12-31 2003-08-31 Pliva Pharm & Chem Works Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
HRP980646B1 (en) * 1998-12-30 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Novel oleandomycin derivatives
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
RU2230748C2 (ru) * 2000-03-15 2004-06-20 Ханми Фарм. Ко., Лтд. Способ получения кларитромицина в виде кристаллов формы ii
JP2004506664A (ja) * 2000-08-23 2004-03-04 ウォックハート・リミテッド 無水アジトロマイシンの製造法
RU2202619C2 (ru) * 2001-01-09 2003-04-20 Научно-исследовательский институт химии Нижегородского государственного университета им. Н.И. Лобачевского Способ определения общей токсичности твердой, жидкой и газообразной сред
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US7271154B2 (en) 2002-02-15 2007-09-18 Merckle Gmbh Antibiotic conjugates
AU2003219770B2 (en) 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1483579A4 (en) 2002-02-15 2006-07-12 Merckle Gmbh CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR MANUFACTURE AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
AU2003264910A1 (en) * 2003-05-30 2005-01-21 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
WO2005021567A1 (en) * 2003-09-02 2005-03-10 Pliva - Istrazivacki Institut D.O.O. O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
PT1851236E (pt) * 2005-01-13 2010-10-25 Glaxosmithkline Zagreb Macrólidos com actividade anti-inflamatória
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
WO2010086350A1 (en) 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 9-deoxo- 9a-methyl- 9a- aza- 9a-h0m0erythr0mycin a derivatives for the treatment of neutrophil dominated inflammatory diseases
CN102378763A (zh) 2009-01-30 2012-03-14 葛兰素集团有限公司 消炎的大环内酯
CN101830949B (zh) * 2009-03-13 2012-05-23 上海医药工业研究院 一种阿奇霉素衍生物、其中间体及其制备方法和应用
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
CN102952166A (zh) * 2011-08-28 2013-03-06 山东方明药业集团股份有限公司 聚合物支载硼氢阴离子还原剂合成阿奇霉素中间体的方法
AU2013239679A1 (en) * 2012-03-27 2014-10-30 Michael W. BURNET Anti-inflammatory macrolides
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
CN110799516A (zh) * 2017-04-20 2020-02-14 来兴泰德基金会 作为抗癌剂的包含鏻离子的阿奇霉素衍生物
CA3060892A1 (en) 2017-04-20 2018-10-25 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
EP3612177A4 (en) 2017-04-21 2021-01-13 Lunella Biotech, Inc. TARGETING HYPOXIC CARCINOUS STEM CELLS (SCC) USING DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY
US11197872B2 (en) 2017-04-21 2021-12-14 Lunella Biotech, Inc. Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
PH12019502594A1 (en) 2017-05-19 2020-10-26 Lunella Biotech Inc Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CA3063450A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
KR102854338B1 (ko) 2017-06-26 2025-09-03 루넬라 바이오테크 인코포레이티드 미토케토신: 암 세포에서 케톤 대사를 표적화하는 미토콘드리아-기반의 치료제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
EP0467331B1 (en) 1995-11-02
HUT62307A (en) 1993-04-28
PL166379B1 (en) 1995-05-31
HRP920491B1 (en) 1998-10-31
HU221803B1 (hu) 2003-01-28
CN1029738C (zh) 1995-09-13
HU9202619D0 (en) 1992-12-28
UA27105A1 (uk) 2000-02-28
CS219591A3 (en) 1992-03-18
CZ280640B6 (cs) 1996-03-13
CN1059728A (zh) 1992-03-25
HRP920491A2 (en) 1994-08-31
BG94837A (bg) 1993-12-24
CA2046956C (en) 1999-01-05
DE69114198D1 (de) 1995-12-07
CA2046956A1 (en) 1992-01-19
JPH05132497A (ja) 1993-05-28
HU9802439D0 (en) 1998-12-28
EP0467331A1 (en) 1992-01-22
RU2045533C1 (ru) 1995-10-10
HUT59935A (en) 1992-07-28
PL291130A1 (en) 1992-11-16
JP2657132B2 (ja) 1997-09-24
GR3018330T3 (en) 1996-03-31
SI9011409A (en) 1995-10-31
SK279075B6 (sk) 1998-06-03
HU215158B (hu) 1998-12-28
RO109338B1 (ro) 1995-01-30
BG60593B1 (bg) 1995-09-29
HU912408D0 (en) 1991-12-30
ES2081397T3 (es) 1996-03-01
HU211659A9 (en) 1995-12-28
DE69114198T2 (de) 1996-06-27
US5250518A (en) 1993-10-05
ATE129715T1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
DK0467331T3 (da) O-methylderivater af azithromycin A, fremgangsmåde og mellemprodukter til fremstilling deraf og anve ndelse deraf ved fremstilling af lægemidler
DK0732338T3 (da) 2,2-difluor-3-carbamoylribosesulfonatforbindelser og fremgangsmåde til fremstilling af beta-nucleosider
DK0879236T3 (da) Derivater af camptothecin til anvendelse ved behandling af cancer
ATE18902T1 (de) Aminosaeurederivate und ihre therapeutischen verwendungen.
MX9600943A (es) Compuestos de piridonsulfonilurea, procedimientos para su produccion y herbicidas que los contienen.
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
DK0464465T3 (da) Substituerede aminoalkylbiphenylderivater, antimykotiske præparater indeholdende disse derivater og mellemprodukter til fremstilling deraf
DK0429627T3 (da) Derivater af quinolin-3-carboxanilider
DK0632805T3 (da) Melaminderivater til anvendelse i behandlingen af cancer
ES2152563T3 (es) Procedimiento para preparar derivados de dihidroxipirimidina.
EP1043312A4 (en) HETEROCYCLIC COMPOUNDS WITH INHIBITING ACTIVITIES
TR199802163T2 (xx) 4'-Triflorometilbifenil-2-karboksilik asit
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
DK0975601T3 (da) Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor
CZ281393B6 (cs) Způsob výroby 6-(substituovaných amino)-propionyl derivátů forskolinu
ES478786A1 (es) Procedimiento para la obtencion de pigmentos de azometina.
TW358114B (en) Diasazo dyestuffs for dyeing cellulosic materials
NO20040113L (no) Variolinderivater og deres anvendelse som antitumormidler
PT98389A (pt) Processo de preparacao de derivados de estreptogramina
FR2619810B1 (fr) Nouveaux monomeres ethyleniques polyfonctionnels
IT1231765B (it) Malte aeree a presa autogena.
DK0533131T3 (da) Fremgangsmåde til selektiv mono-ortho-hydroxy-alkylering af 4-substituerede pyridin-derivater
DK0678515T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 5-oxaspiro[2.4]heptan-on
DK112392A (da) Bis(aminomethyl)bicyklooe2,2,1aaheptan-derivater og anvendelsen deraf til inhibering af udfaeldning af metalioner fra deres vandige oploesninger
AR007463A1 (es) Colorantes monoazoicos sustituidos por grupos haloalquilcarbamato y sulfonilfluoruro